-
Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy2020 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access cited by 1 patent
Iris Noordhoek, Kai Treuner, Hein Putter, Yi Zhang, Jenna Wong, Elma Meershoek‐Klein Kranenbarg, +4 more
133citations -
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer2021 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Bruno Valentin Sinn, Sibylle Loibl, Claus Alexander Hanusch, Dirk-Michael Zahm, Hans‐Peter Sinn, Michael Untch, +16 more
46citations -
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial2020 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Thomas Karn, Tobias Meißner, Karsten Ernst Weber, Christine Solbach, Carsten Denkert, Knut Engels, +19 more
16citations -
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial2022 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer, Matthias Christgen, Jenci Palatty, +21 more
14citations -
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials2024 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Paul Jank, Thomas Karn, Marion van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, +18 more
13citations -
Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features2023 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Hanne Lefrère, Kat S Moore, Giuseppe Floris, Joyce Sanders, Iris M. Seignette, Tycho Bismeijer, +17 more
10citations -
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial2023 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Peter Andreas Fasching, Christopher W. Szeto, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Patricia Spilman, +18 more
8citations -
Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial2023 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Terence Marques Williams, Andreas Schneeweiß, Christian Jackisch, Changxian Shen, Karsten Ernst Weber, Peter Andreas Fasching, +16 more
7citations -
Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial2024 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
John M.S. Bartlett, Keying Xu, Jenna Wong, Gregory R. Pond, Yi Zhang, Melanie Spears, +11 more
6citations -
Abstract GS2-11: Omission of sentinel lymph node biopsy in clinically T1-2 node-negative breast cancer patients treated with breast-conserving therapy: results of the Dutch BOOG 2013-08 randomized controlled trial after a median follow-up of 5 years2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
R. J. Schipper, L. van Roozendaal, V. Wintraecken, J.M. Simons, Martine Moossdorff, E.J.T. Luiten, +36 more
6citations -
Abstract GS2-01: More versus less invasive axillary surgical staging procedures in breast cancer patients converting from a clinically node-positive to a clinically node-negative stage through neoadjuvant chemotherapy - primary endpoint analysis of the international prospective multicenter AXSANA/EUBREAST 3(R)study2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Thorsten Kühn, M. Banys-Paluchowski, Nina Caroline Ditsch, Elmar Stickeler, Michael Hauptmann, J. Schroth, +43 more
4citations -
Abstract RF2-01: Prognostic Markers in Residual Tumors after neoadjuvant chemotherapy (NACT) for Early Triple-negative Breast Cancer (TNBC) - a Pooled Analysis from nine Neoadjuvant GBG/AGO-B Trials2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Johannes Holtschmidt, A. Schneeweiss, Nadine Frickel, Natalie Filmann, Michael Untch, A. D. Hartkopf, +20 more
3citations -
Identification of Early-Stage Breast Cancer with a Minimal Risk of Recurrence by the Breast Cancer Index2025 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Marie-France Jilderda, Yi Zhang, Valerie Rebattu, Ranelle C. Salunga, Wilma E. Mesker, Jenna Wong, +8 more
3citations -
Abstract A051: Multi-omic explainable machine learning improves cancer treatment outcome prediction2025 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Khoa Anh Tran, Venkateswar Addala, Lambros T. Koufariotis, Jia Zhang, Scott Wood, Conrad Leonard, +10 more
2citations -
Abstract PS4-08-07: Predicting response and survival after neoadjuvant systemic treatment with on-treatment biopsies2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
C. Denkert, A. Schneeweiss, V Schaser, Michael Untch, M. Van Mackelenbergh, J.-U. Blohmer, +17 more
0citations -
Abstract PS1-12-19: Disease natural history and care quality assessment of hormone receptor positive / human epidermal growth factor receptor 2 negative metastatic breast cancer (HR+/HER2- mBC) - an international multicentric study2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Stelios Theophanous, L. Revie, O. Bouissou, François P. Duhoux, Prabash Galgane Banduge, Ananya Choudhury, +18 more
0citations -
Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial2026 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Christine Desmedt, Ha-Linh Nguyen, Sabine C. Linn, Otto Metzger, Coralie Poncet, Jelle Wesseling, +13 more
0citations
17 results